Literature DB >> 18090715

Cardiac arrest, mild therapeutic hypothermia, and unanticipated cerebral recovery.

Demetris Yannopoulos1, Konstantinos Kotsifas, Tom P Aufderheide, Keith G Lurie.   

Abstract

OBJECTIVES: Animal and human studies support mild therapeutic hypothermia as an effective means of preventing brain injury in comatose patients resuscitated from cardiac arrest. However, there is little clinical experience with predicting neurologic outcome in this patient population. We present 4 comatose patients resuscitated from cardiac arrest treated with mild hypothermia whose in-hospital neurologic prognosis was determined by board-certified neurologists to be grave, yet were ultimately discharged from the hospital with no or minimal neurologic sequelae.
RESULTS: We report 4 comatose patients resuscitated from cardiac arrest treated with mild hypothermia. On hospital admission, all patients had a Glasgow Coma Score between 3 and 6 and a FOUR Score between 1 and 5. Mild hypothermia (32 degrees C - 33 degrees C) was implemented for 24 to 40 hours. Examination by board-certified neurologists before and during hypothermia or the rewarming phase suggested a grave prognosis. All 4 patients had sudden and dramatic neurologic recovery 9 to 24 hours after rewarming to normothermia and were ultimately discharged with no or minimal neurocognitive sequelae.
CONCLUSION: This case series suggests that neurologic assessment-based prognosis of patients after cardiac arrest undergoing therapeutic mild hypothermia should be considered unreliable for at least the first 72 hours. Use of additional assessments such as brain injury markers or evoked potentials, in addition to clinical examination, should be strongly considered to help determine an estimated prognosis. Functional reversibility after a global insult could be an intrinsic potential of the brain, similar to myocardial stunning, and deserves investigation.

Entities:  

Mesh:

Year:  2007        PMID: 18090715     DOI: 10.1097/NRL.0b013e3180de4dc3

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  7 in total

1.  Automated quantitative pupillometry for the prognostication of coma after cardiac arrest.

Authors:  Tamarah Suys; Pierre Bouzat; Pedro Marques-Vidal; Nathalie Sala; Jean-François Payen; Andrea O Rossetti; Mauro Oddo
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

2.  From laboratory science to six emergency medical services systems: New understanding of the physiology of cardiopulmonary resuscitation increases survival rates after cardiac arrest.

Authors:  Tom P Aufderheide; Carly Alexander; Charles Lick; Brent Myers; Laurie Romig; Levon Vartanian; Joseph Stothert; Scott McKnite; Tim Matsuura; Demetris Yannopoulos; Keith Lurie
Journal:  Crit Care Med       Date:  2008-11       Impact factor: 7.598

Review 3.  Performing the Brain Death Examination and the Declaration of Pediatric Brain Death.

Authors:  Susan D Martin; Melissa B Porter
Journal:  J Pediatr Intensive Care       Date:  2017-06-27

4.  Timing of neuroprognostication in postcardiac arrest therapeutic hypothermia*.

Authors:  Sarah M Perman; James N Kirkpatrick; Angelique M Reitsma; David F Gaieski; Bonnie Lau; Thomas M Smith; Marion Leary; Barry D Fuchs; Joshua M Levine; Benjamin S Abella; Lance B Becker; Raina M Merchant
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

5.  Coma due to cardiac arrest: prognosis and contemporary treatment.

Authors:  Donald W Marion
Journal:  F1000 Med Rep       Date:  2009-11-26

6.  Improved survival in the real world with revised cardiopulmonary resuscitation guidelines: doing better out of hospital but not out of the woods yet.

Authors:  Subha Varahan; Ruchir Sehra; Sanjiv M Narayan
Journal:  Heart Rhythm       Date:  2010-05-19       Impact factor: 6.343

Review 7.  Enhancing cardiac arrest survival with extracorporeal cardiopulmonary resuscitation: insights into the process of death.

Authors:  Tom P Aufderheide; Rajat Kalra; Marinos Kosmopoulos; Jason A Bartos; Demetris Yannopoulos
Journal:  Ann N Y Acad Sci       Date:  2021-02-20       Impact factor: 5.691

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.